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ABSTRACT: Hepatic Angiosarcoma is a rare malignancy of 
endothelial cell origin that is generally idiopathic and presents 
non-specific clinical manifestations. Hemoperitoneum can occur 
in 17-27% of cases and is a result of tumor rupture, which has a 
devastating prognosis. We present a 79-year-old female patient with 
history of diffuse right upper quadrant abdominal pain associated with 
syncope episodes and unintentional weight loss. Physical examination 
was unremarkable except for painful palpation of the right upper 
quadrant. Laboratory exams indicated chronic disease anemia, a 2.7 
INR, decreased albumin, increased C-Reactive Protein and GGT, and 
normal AST, ALT, Alkaline Phosphatase and Bilirubin. Viral hepatitis 
serologies were negative. Abdominal ultrasonography revealed 
hepatomegaly and solid liver lesions of heterogeneous echogenicity 
and imprecise limits. Three-phase abdominal CT showed multiple 
liver masses of heterogeneous pattern of enhancement suggestive 
of atypical hemangioma associated with ascites. Chest CT revealed 
bilateral pulmonary nodules suggestive of metastasis. During hospital 
stay, the patient developed a massive hemoperitoneum that required 
emergency laparotomy. In this circumstance, liver and omentum 
biopsies were performed and the pathology reports ultimately 
indicated the possibility of hepatic angiosarcoma.  The patient 
developed refractory hemoperitoneum and hemorrhagic shock and 
ultimately passed away, 48 days after hospital admission. Definitive 
diagnosis was only available posteriorly, with immunohistochemistry 
positivity for ERG, CD34 and Factor VIII-related antigen on both 
omentum and lung samples. This case study provides valuable 
clinical discussion and emphasizes how a transdisciplinary approach 
is essential to correctly diagnose and manage such complex cases.
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RESUMO: O Angiossarcoma Hepático é uma malignidade rara 
de origem endotelial que é geralmente idiopática e apresenta 
manifestações clínicas inespecíficas. Hemoperitônio pode ocorrer 
em 17-27% dos casos e resulta da ruptura tumoral, o que tem um 
prognóstico devastador. Apresentamos uma paciente de 79 anos, do 
sexo feminino, com história de dor difusa em quadrante abdominal 
superior direito, associada a episódios de síncope e perda de peso 
não intencional. O exame físico era pouco notável, exceto por 
palpação dolorosa do quadrante superior direito do abdome. Exames 
laboratoriais indicaram anemia de doença crônica, RNI de 2.7, 
Albumina reduzida, Proteina C-Reativa e GGT elevados e níveis 
normais de AST, ALT, Fosfatase Alcalina e Bilirrubinas. Sorologias 
para hepatites virais foram negativas. Ultrassonografia abdominal 
revelou hepatomegalia e lesões hepáticas sólidas de ecogenicidade 
heterogênea e limites imprecisos. TC abdominal em três fases mostrou 
múltiplas massas hepáticas com padrão de realce heterogêneo, 
sugestivo de hemangioma atípico, e ascite. TC de tórax revelou 
nódulos pulmonares bilaterais sugestivos de metástases. Durante a 
internação, a paciente desenvolveu hemoperitônio maciço e necessitou 
de laparotomia de emergência. Nessa circunstância, biópsias do 
fígado e do omento foram realizadas e os relatórios de estudo 
anatomo-patológico indicaram, em última análise, possibilidade 
de angiossarcoma hepático. A paciente desenvolveu hemoperitônio 
refratário e choque hemorrágico e, por fim, faleceu 48 dias após 
admissão hospitalar. O diagnóstico definitivo tornou-se disponível 
posteriormente, com estudo imuno-histoquímico positivo para ERG, 
CD34 e antígeno relacionado ao fator VIII nas amostras de omento e 
pulmões. Este estudo de caso proporciona valiosa discussão clínica 
e enfatiza como uma abordagem transdisciplinar é essencial para 
diagnosticar e manejar corretamente casos tão complexos.
Palavras-chave: Hemangiossarcoma; Hemoperitônio; Neoplasias 
Hepáticas
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INTRODUCTION
Hepatic angiosarcoma is the third most common primary malignancy of the liver. It is a 
rare but aggressive neoplasm of endothelial cell origin 
that presents with non-specific clinical manifestations 
like abdominal pain, fatigue and weight loss. The main 
differential diagnosis include benign and malignant hepatic 
neoplasms, particularly hemangioma and metastatic 
disease. Investigation must be comprehensive and requires 
a transdisciplinary approach in order to obtain accurate 
diagnosis and adequate treatment. In this case report, 
we aim to present the unusual clinical manifestations, 
diagnostic evaluation and initial management of a patient 
with hepatic angiosarcoma manifested as hemoperitoneum. 
Our objective is to share the knowledge we obtained from 
studying it and to emphasize the characteristics of this 
rare disease to contribute to education of future health 
care providers.  
CASE REPORT 
A 79-year-old female patient presented to the 
emergency room with a history of vague right upper 
quadrant abdominal pain for the past two months that 
became more intense in the past few days. In addition, she 
referred episodes of hypotension and syncope, that started 
two weeks before, and unintentional weight loss over the 
past few months. She denied fever, nausea, vomiting, 
diarrhea and external bleeding. Her comorbidities were 
hypothyroidism, atrial fibrillation and vitiligo. She denied 
alcohol consumption, smoking and drug use and her other 
aspects of her history were unremarkable. She routinely 
took the following medications: Rivaroxaban, Propafenone, 
Levothyroxine and Pantoprazole. 
During initial evaluation she presented anicteric, 
acyanotic, with normal vital signs. Physical examination 
was unaltered except for an abdomen slightly rigid and 
painful to palpation of the right upper quadrant, with 
no palpable masses, no guarding or signs of peritoneal 
irritation.
An abdominal ultrasonography, a laboratory workup 
and Holter monitoring were requested. Her laboratory 
exams results were: 
Hemoglobin: 8.1 mg/dl; Red Blood Cells: 2.71 
millions/mm3; Hematocrit: 25.9%; MCV: 95.6 
fL; MCH: 29.9 pg; MCHC: 31.3%, RDW: 15.2%; 
White Blood Cells: 10.02 x 109/L; 218.000 
Platelets; Serum Iron: 38 mcg/dL; Ferritin: 322.3 
ng/mL; Total Iron Binding Capacity: 185 mcg/
dL; Transferrin Saturation: 17%; Prothrombin 
Activity: 32.5%; Prothrombin time: 27.9 seconds; 
INR: 2.7; Albumin: 2.8 g/dL; C-reactive Protein: 
77 mg/dl; Urea: 49 mg/dl; Creatinine: 0.81 mg/
dL; AST: 24 U/L; ALT: 27 U/L; GGT:106 U/L; 
Alkaline Phosphatase: 125 U/;  0.7 mg/dl Total 
bilirubin, 0.31mg/dl Direct bilirubin; Anti-HCV: 
Non-reactive; HBsAg: Non-reactive; Anti-HBs: 
1000 mUI/ml; Anti-HIV 1 and 2: Non-reactive.
Abdominal ultrasonography showed presence of 
small ascites and an enlarged liver with expansive solid 
lesions of heterogeneous aspect and imprecise limits, 
on the right lobe and part of the left lobe, with modest 
vascularization on Doppler mapping. The largest lesions 
measured about 10 x 7,5 cm and 6,7 x 6 cm.  
Figure 1. Abdominal Ultrasonography. A: expansive lesion on the right lobe of the liver of heterogeneous echogenicity and imprecise 
limits. B: Expansive lesion on the left lobe of the liver of heterogeneous echogenicity
In sequence, the patient was admitted and 
Rivaroxaban was suspended. She received intramuscular 
vitamin K and was started on daily 40 mg subcutaneous 
enoxaparin. 
Chest and abdomen CT were requested in sequence. 
Abdomen CT was performed with intravenous contrast in 
three phases. It indicated hepatomegaly associated with 
multiple hepatic nodules in both right and left lobes, some 
with central hemorrhagic areas, suggestive of secondary 
dissemination; Small ascites containing hyperdense 
material in the right paracolic gutter, likely corresponding 
to blood; Mesoabdominal fat hyperdensity. 
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Figure 2. Abdominal CT Scan. A: Non-enhanced Abdominal CT Scan. B: Enhanced CT scan during early hepatic 
arterial phase. C: Portal venous phase. D: Equilibrium phase
Chest CT indicated bilateral pulmonary nodules, 
compatible with secondary neoplastic lesions; Soft-tissue 
density nodules, varied in size, with random distribution 
across the pulmonary parenchyma bilaterally; The 
largest nodules are located in the apical-posterior and 
basal posterior segments of the superior and inferior left 
lobe, respectively; Cyst in the superior right lobe; Cystic 
mediastinal formation alongside the pericardium, likely 
corresponding to pericardial cyst; Minimal pleural effusion 
to the right; Cardiomegaly. Hiatal hernia; Discrete aortic 
atheromatosis.
Within 36 hours of hospital admission, the patient 
developed hemodynamic collapse with tachycardia, 
tachypnea, severe pallor and important decline of mental 
status, associated with severe abdominal distention. There 
was significant hemoglobin decrease from admission to 
5.2 mg/dl, mild thrombocytopenia, acidosis and elevated 
lactate level.
An exploratory laparotomy was conducted, 
revealing a massive hemoperitoneum. Large solid liver 
lesions with hemangioma aspect were spotted, as well as 
smaller lesions on the omentum of similar aspect. About 
four liters of blood were drained but there were no signs 
of active bleeding.  Intraoperative biopsy of liver and 
omentum lesions was performed.
The patient was admitted to the ICU, where she 
received blood transfusions and was maintained stable 
with the use of vasopressors until post-operative day 8, 
after which she was discharged from the ICU and awaited 
further diagnostic evaluation.
Histopathologic analysis results were available a 
week after surgery. Hepatic sample was a 1,5 x 1 x 0,5 cm 
irregular fragment. Microscopic examination indicated 
capsular thickening; hematic and lymphatic lakes in the 
subcapsular parenchyma; sinusoidal dilation; thick fibrous 
septae, lymphocyte and monocyte infiltration; no signs 
of neoplasia; cannot exclude possibility of fibrous cyst. 
Omental sample was a 2 x 2 x 1 cm irregular fragment that 
indicated fibroadipose tissue with cavernous hemangioma. 
After  consider ing the  pat ient’s  c l in ical 
manifestations, the natural history of hemangiomas and 
the adverse conditions in which the biopsies were obtained, 
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a review of the analysis was requested and a biopsy of the 
pulmonary nodules was planned and performed about ten 
days later, after patient’s clinical stabilization.
Ten days after the pulmonary biopsy, the patient developed 
new hemodynamic collapse and severe abdominal 
distention. She received 900 ml of packed red blood cells 
and 600 ml of frozen plasma and was urgently submitted to 
laparotomy. About 5 liters of blood were drained from the 
peritoneal cavity and a large hepatic mass on the segment 7 
of the liver was encountered, with active signs of bleeding. 
Hemorrhagic spots were seen on the omentum as well. A 
damage control surgery approach was adopted: Extensive 
hepatorrhaphy was performed and the abdomen was packed 
in the site of hepatic bleeding and temporarily closed, to 
be assessed again in 48 hours once the patient was stable.
Two days later the patient was reassessed and 
the packs were removed from the abdomen. The 
abdominal cavity was re-evaluated and showed no signs of 
hemorrhage, allowing the surgeons to proceed to definitive 
closure of the abdominal wall. 
Figure 3. Macroscopic appearance of the liver during second-look laparotomy following a massive hemoperitoneum. A: Enlarged liver 
with no signs of active hemorrhage. B: Omental metastatic lesion, or “omental cake”, spotted during laparotomy
Results of the review of the omentum sample 
pathological analysis were available five days after her 
last laparotomy, and showed: circumscribed neoplasm 
composed of anastomosing vascular channels that formed 
cavernous structures of varied sizes, with abundant 
hemorrhagic material and necrotic foci; the cells lining 
the vascular channels are fusiform and present oval nuclei, 
with discrete atypia and evident nucleoli. The conclusion 
was that the findings were suggestive of angiosarcoma.
Histopathologic examination of the pulmonary 
biopsy revealed various small nodules composed of 
small anastomosing vascular channels, at times forming 
cavernous structures. They are lined by fusiform cells 
with elongated nuclei, with discrete pleomorphism and 
evident nucleoli. The conclusion was that the findings were 
suggestive of angiosarcoma. 
In  o rder  to  conf i rm the  d iagnos i s ,  an 
immunohistochemistry study was requested. Concurrently, 
an Angio-CT was planned to provide anatomical study of 
the tumor vasculature.
The case was considered surgically unresectable 
due to multiple, infiltrative, hepatic masses and metastasis 
to other organs. The therapeutic proposal offered was 
embolization, to reduce size and risk of hemorrhage, and 
palliative chemotherapy. However, shortly after the patient 
developed another episode of hemorrhagic shock, which 
ultimately resulted in her death, 48 days after admission. 
Immunohistochemistry analysis reports posteriorly 
informed: Both the omentum and pulmonary samples tested 
positive for ERG, CD34, Factor VIII-related antigen and 
negative to cytokeratin and epithelial membrane antigen; 
50-60% of omentum sample cells and only 25-30% of 
pulmonary cells were positive to Ki 67. The diagnosis of 
angiosarcoma was, therefore, confirmed. 
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Figure 4. Histology. A: Lung biopsy sample: communicating vascular channels, lined by atypical endothelial cells, containing red blood 
cells. B: Omentum biopsy sample: formation of cavity filled with blood and ruptured abnormal vascular channels within the tissue
DISCUSSION
In this report, we present a case of idiopathic hepatic 
angiosarcoma diagnosed in the event of a spontaneous 
hemoperitoneum that lead to hemorrhagic shock. The 
patient’s presentation at the emergency room suggested 
several possible causes, leading to a comprehensive initial 
evaluation. Posterior investigation was greatly guided by 
the finding of a hepatic mass on ultrasound and occurrence 
of intraabdominal bleeding, which pointed a direction 
towards the most likely diagnosis.
Spontaneous hemoperitoneum is the clinical entity 
in which there is blood within the peritoneal cavity from 
a non-traumatic and non-iatrogenic cause1,2. Symptoms 
can be non-specific although abdominal pain is frequently 
reported. Benign and malignant hepatic conditions can 
cause hemorrhage, with hepatic adenomas being the most 
frequent benign neoplasms and hepatocellular carcinoma 
the most frequent malignant neoplasm associated. 
Malignant disease more often causes liver rupture, with 
HCC accounting for the majority of cases and metastatic 
disease for less than 2% of cases1.
Rupture of a hepatic angiosarcoma leading to 
hemoperitoneum is a possible clinical manifestation of 
this malignancy, which happens in about 17-27% of cases3. 
Angiosarcomas are a subtype of soft-tissue sarcoma, 
originated from endothelial cells of blood and lymphatic 
vessels, that represent about 2% of soft tissue sarcomas, 
and 2% of all primary liver tumors4,5. It is the third most 
common primary malignancy of the liver in adults and the 
first of mesenchymal origin. Hepatic angiosarcomas occur 
more often in the sixth and seventh decades of life and is 
4 times more frequent in men than in women6. Metastasis 
occur more often in the lungs, through hematogenous 
dissemination, but can also appear in the bones and soft-
tissue structures5. Etiology is idiopathic in the majority of 
cases, although some risk factors have been established. 
Environmental exposure to chemicals such as thorotrast, 
polyvinyl chloride and arsenic powder has been largely 
implicated in the development of this malignancy3,5,7. 
Clinical manifestations are varied. The most common 
presenting symptoms are upper abdominal pain, abdominal 
swelling, weight loss and nausea.6 Physical examination 
signs frequently reported are hepatomegaly, ascites and 
jaundice7,8.
In the case we reported, the patient’s laboratory 
exams featured a normocytic/normochromic anemia with 
decreased serum iron and transferrin saturation and elevated 
ferritin, highly suggestive of chronic disease anemia. 
Moreover, she presented markedly elevated thrombin time 
and INR, and decreased prothrombin activity, which reflects 
dysfunction of the extrinsic pathway of coagulation. In this 
context, it could be due to a hepatic disease coagulopathy, 
in which synthesis of clotting factors is reduced or occurs 
abnormally leading to impairment of coagulation. Hepatic 
angiosarcoma has been linked to clotting abnormalities 
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and thrombocytopenia predisposing to hemorrhages 
in other studies, sometimes correlated with anemia 
and hemoperitoneum3,8,9. Disseminated intravascular 
coagulopathy is a possible but rare manifestation that has 
been reported in about 5% of cases7,10.
Decreased albumin has also been linked to this 
malignancy and reflects impaired synthetic function.7 It 
is important to consider that other factors can alter serum 
albumin such as nutritional status and catabolism, while 
prothrombin time can be altered in vitamin K deficiency, 
warfarin anticoagulation and consumptive coagulopathy. 
Regarding the assessment of hepatocellular injury, 
biliary tract and excretory function, the patient presented 
unaltered AST and ALT, total and direct bilirubin within 
normal ranges, markedly elevated GGT and borderline 
alkaline phosphatase. These findings were, therefore, 
limited to identify the predominant pattern of liver 
abnormality. Elevated GGT has been reported in hepatic 
angiosarcoma and, in this scenario, could be caused 
by the expansive lesion. Laboratory results in hepatic 
angiosarcoma are often non-specific, but moderately 
elevated AST and ALT, elevated alkaline phosphatase 
and thrombocytopenia are frequently reported in studies. 
Tumor markers are most commonly negative or only mildly 
elevated, similarly to our case, in which CEA, AFP, CA 
19-9, CA 15-3, CA 125 were all within normal ranges3,7,8. 
The primary purpose of these markers is to raise suspicion 
of HCC, metastatic disease and other malignancies, with 
AFP being the most helpful marker to evaluate HCC6. 
Viral hepatitis was evaluated in our case by ordering 
Anti-HBs, HBsAg and Anti-HCV. The results suggested 
previous vaccination for hepatitis B and negative serology 
for acute hepatitis B and C. Total Anti-HBc and Anti-HBc 
IgM would be useful in this scenario to exclude previous 
acute hepatitis B. 
Imaging studies are useful to support clinical 
investigation, especially regarding the differential diagnosis 
of solid liver lesions. In our case, the liver lesion presented 
poorly defined masses of heterogeneous echogenicity 
on ultrasound. It was hypo or isodense compared to the 
parenchyma on non-enhanced CT and on contrast-enhanced 
CT it showed heterogeneous pattern of enhancement during 
arterial and portal venous phase, with areas suggestive of 
necrosis and hemorrhage.  The main hypothesis suggested 
by these findings was of atypical hemangioma. 
Hemangiomas usually present on ultrasound 
as well defined hyperechogenic nodules that could be 
hypoechogenic in the center due to fibrosis, necrosis or 
calcification. On non-enhanced CT, usual presentation is 
of a nodular homogeneous lesion, hypodense compared to 
the normal parenchyma. After administration of contrast, 
the lesion shows peripheral centripetal enhancement, 
with attenuation coefficient similar to the aorta. Delayed 
scans show density of the lesion similar or superior to 
the liver parenchyma. Atypical hemangiomas may show 
other patterns such as delayed enhancement and central 
enhancement without centripetal fill-in. Furthermore, 
presence of intralesional hemorrhage, fibrosis and necrosis 
could lead to a heterogeneous pattern on imaging studies 
that confuse diagnosis. Differential diagnosis is made 
with other solid liver lesions like adenomas, that could 
present heterogenous arterial enhancement with areas of 
hemorrhage and calcification in atypical cases, and hepatic 
angiosarcoma11. 
Regarding hepatic angiosarcoma, ultrasound image 
can show single or multiple lesions with heterogeneous 
echogenicity due to necrosis and hemorrhage.3 On non-
enhanced CT, the lesions can either be multiple or singular 
and may be predominantly hypodense with hyperdense 
spots due to recent hemorrhage. Hypodense areas may 
occur as a result of necrosis and old hemorrhage. After 
administration of contrast, the lesions show a heterogeneous 
pattern of enhancement, with spots of density superior to 
the liver parenchyma but inferior to the aorta. Enhancement 
develops progressively on delayed scans, with some areas 
remaining hypodense due to fibrosis or necrosis11,12.
Biopsy and histopathologic analysis are paramount 
to establish definitive diagnosis. Clinical correlation to 
the findings is essential to the pathologist. In this case, for 
instance, the presence of pulmonary nodules and a history 
suggestive of rapid tumor growth were responsible for 
the suspicion of angiosarcoma. Although intraoperative 
biopsy was performed opportunely during an emergency 
laparotomy, the quality of the fragments obtained was 
suboptimal, due to the context, and clinical correlation 
was impaired because the biopsy was performed before 
the case could be properly discussed. Thus, a review of 
the initial analysis was necessary, which could have been 
prevented by performing planned surgical biopsy and 
correlation to clinical history. Percutaneous biopsy is not 
recommended because of the vascular nature of the tumor 
and the possibility of hemorrhage4,7.
Macroscopically, hepatic angiosarcomas usually 
involve both lobes of the liver and more frequently presents 
as a large dominant mass but could also present as multiple 
nodules or diffuse micronodular infiltration. Histological 
evaluation may show highly atypical pleomorphic 
sinusoidal endothelial cells with hyperchromatic nuclei, 
which line blood spaces and grow in a confluent infiltrative 
manner along sinusoids and other vascular channels. 
Endothelial cells often present a spindle or polygonal 
morphology. Solid areas resembling fibrosarcoma may be 
seen, as well as numerous mitotic figures. Areas of infarct, 
atrophy, fibrosis and calcification are frequent4,13.
Immunohistochemistry allows diagnostic 
confirmation by studying expression of specific molecular 
markers. CD31, CD34 and factor VIII-related antigen are 
markers expressed in endothelial cells that have been used 
to confirm the vascular nature of the tumor. Recently, ERG, 
a transcription factor expressed in endothelial cells, was 
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reported to be superior in diagnosis of angiosarcoma than 
other markers13. However, up to this point, no markers were 
associated with prediction of prognosis4,8.
There are few studies reporting survival rates of 
hepatic angiosarcoma. A review of the literature from 
1979 indicated that only 3% of patients with primary 
hepatic angiosarcoma survive longer than 2 years, with a 
median survival of 6 months, without treatment7. Complete 
surgical resection is considered to be the only definitive 
treatment that can improve survival.8 Still, like our case, 
most cases present multifocal lesions and are unresectable 
at diagnosis. In these patients, palliative chemotherapy 
could be an option and several treatment modalities have 
been reported, with no established chemotherapy regimen. 
Primary hepatic angiosarcoma is reported as a radioresistant 
and radiotherapy is usually not indicated3,14. Liver 
transplantation is contraindicated due to the high recurrence 
rates. Rupture of hepatic angiosarcoma has a devastating 
prognosis despite surgery or arterial embolization. As 
seen in our case, tumor dissemination and peritoneal 
angiosarcomatosis cannot be managed effectively through 
surgery and can induce massive blood loss15.
CONCLUSION 
Hepatic angiosarcoma is a rare malignancy 
that consists in a diagnostic challenge that requires 
transdisciplinary medical evaluation. The non-specific 
presentation and differential diagnosis with other hepatic 
neoplasms demands comprehensive understanding of 
the manifestations of hepatic diseases and a high level of 
suspicion. Blood tests may show altered hepatic function 
and imaging studies provide characterization of the 
neoplasm but diagnosis is only established definitively by 
surgical biopsy and pathologic analysis. Angiosarcoma 
is an aggressive tumor and complete surgical resection 
is the most effective treatment when possible, with 
palliative chemotherapy being a prominent option for 
those not eligible for surgery. Further research is required, 
particularly to improve management and survival of 
these patients. Studying such cases allows the future 
professionals to learn from every manifestation, contributes 
to continued education and motivates medical research in 
areas that could significantly improve patient care.
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